***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we closed one position for a gain.

PLURISTEM THERAPEUTICS (3/20/11). Closed position 7/11/11 at $3.65 for a 56% GAIN.

A report that stem cells grown from bone marrow replaced a man’s cancer-ridden windpipe helped propel many stem cell stocks with Pluristem Therapeutics being one of them as it pierced our 50%-plus threshold.

(more…)

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we have closed two more positions; one for a gain and the other for a loss.

ADVENTRX PHARMACEUTICALS (2/20/11). Closed position 6/29/11 at $3.24 for a 55% GAIN.

ENERGY FOCUS (6/5/08). Closed position 6/29/11 at 50 cents for a 79% LOSS.

AdventRx Pharmaceuticals got a nice boost when two brokerage houses came out with targets on the stock of $7.50 and $14 respectively. Overly optimistic? We don’t know, but we are happy to take the gain at current prices. After a long siege, we finally closed Energy Focus for a loss.

(more…)

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we closed one position, for a gain.

NAPCO SECURITY TECHNOLOGIES (7/5/10). Closed position 6/13/11 at $2.76 for a 50% GAIN.

NAPCO Security had a nice pop over the last few weeks, despite a lousy market. One can only imagine if the stock would have gone much higher in a better environment.

(more…)

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we closed three positions; two for some nice gains and one for a loss.

ADVANCED ANALOGIC TECHNOLOGIES (9/20/10). Closed position 5/27/11 at $6.04 for a 78% GAIN.

BIOSANTE PHARMACEUTICALS (9/20/09). Closed position 5/24/11 at $3.02 for a 61% GAIN.

LINKTONE (11/5/07). Closed position 5/26/11 at $1.02 for a 70% LOSS.

(more…)

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we have closed three more positions, one for a nice gain, one for a very modest gain, and another for a loss.

Vical, Inc. (4/5/11). Closed position 5/13/11 at $4.95 for a 68% GAIN.

Banner Corp. (8/5/10). Closed position 5/13/11 at $2.81 for a 20% GAIN.

NIVS IntelliMedia (1/20/10). Closed position 5/13/11 at $1.00 for a 71% LOSS.

(more…)

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

In the last Newsletter, we said the markets looked tired, but every time we have expected a sell off, the averages keep moving upward. And, surprise that is exactly what happened, thanks to the Fed’s constant overly-generous helpings of liquidity. Of course, the adverse effects to this are higher commodity and oil prices, due to an ever falling dollar. As the deficits keep piling up and the Fed continues to print money, investors are flocking to commodities; and the oil producers keep raising their prices to protect themselves from the ever-shrinking dollar – supply and demand has little to do with it. It is sort of like watching a hamster on a wheel. The problem is that we are the hamster.

(more…)

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we closed two positions; one for a gain and the other for a loss.

INHIBITEX (3/5/11). Closed position 4/1/11 at $4.78 for a 103% GAIN.

OILSANDS QUEST (10/20/08). Closed position 4/1/11 at 50 cents for a 66% LOSS.

(more…)

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we closed two more positions, one for a gain and another for a loss.

BIOCLINICA (8/5/09). Closed position 3/23/11 at $5.57 for a 55% GAIN.

CATALYST PHARMACEUTICAL (12/20/07). Closed position 3/23/11 at $1.12 for a 63% LOSS.

(more…)

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we closed four more positions; three for gains and one for a loss.

BIOLASE TECHNOLOGY (4/5/08). Closed position 3/11/11 at $4.90 for 60% GAIN.

DUSA PHARMACEUTICALS (6/5/10). Closed position 3/3/11 at $4.34 for a 100% GAIN.

IDENTIVE GROUP (10/5/08). Closed position 3/3/11 at $3.50 for a 52% GAIN.

NEUROMETRIX (3/20/10). Closed position 3/3/11 at 52 cents for a 74% LOSS.

(more…)

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

No need to do a double –take; we did not close any positions since the last Newsletter, but considering that we closed over 30 since early November, we can’t be too stressed out over the situation. The downdraft from the markets, obviously, spilled over onto our Current Portfolio, but, for now, it hasn’t been as bad as it could have been. Currently, the markets seem to be calming because the Saudi king is throwing his money around the kingdom, about $32 billion of it. Smart man, considering the royal family is supposedly worth $240 billion. Short term, the markets’ fate is determined by the price of oil. Same goes for the medium and long-term future of the markets. Sound overly simplistic? Not really.

(more…)